Laurent Pharmaceuticals

Laurent Pharmaceuticals is a private biopharmaceutical company dedicated to developing orally active drug candidates at the clinical stage. The company has a clinical-stage drug development program (LAU-7b) aimed at addressing the impaired immune-inflammatory response in cystic fibrosis (CF), which is a key factor leading to insufficient lung function in CF patients.